Viral hepatitis C.
Poynard T, Yuen MF, Ratziu V, Lai CL.
Lancet. 2003 Dec 20;362(9401):2095-100. doi: 10.1016/s0140-6736(03)15109-4.
Viral hepatitis C pandemic: Challenges and threats to its elimination.
Krekulova L, Honzák R, Riley LW.
J Viral Hepat. 2021 May;28(5):694-698. doi: 10.1111/jvh.13480. Epub 2021 Feb 24.
Viral hepatitis C.
Czepiel J, Biesiada G, Mach T.
Pol Arch Med Wewn. 2008 Dec;118(12):734-40.
Viral Hepatitis C: From Unraveling the Nature of Disease to Cure and Global Elimination.
Basyte-Bacevice V, Kupcinskas L.
Dig Dis. 2024;42(5):486-495. doi: 10.1159/000539210. Epub 2024 May 8.
Viral Hepatitis C Therapy: Pharmacokinetic and Pharmacodynamic Considerations: A 2019 Update.
Smolders EJ, Jansen AME, Ter Horst PGJ, Rockstroh J, Back DJ, Burger DM.
Clin Pharmacokinet. 2019 Oct;58(10):1237-1263. doi: 10.1007/s40262-019-00774-0.
[Viral hepatitis C].
Aprosina ZG, Ignatova TM, Krel' PE.
Arkh Patol. 1994 Nov-Dec;56(6):79-82.
[Viral hepatitis C].
Zeuzem S, Roth WK, Herrmann G.
Z Gastroenterol. 1995 Feb;33(2):117-32.
Viral hepatitis C.
Smith AD, Rockey DC.
Lancet. 2004 Feb 21;363(9409):661. doi: 10.1016/S0140-6736(04)15609-2.
Glucocorticosteroids for viral hepatitis C.
Brok J, Mellerup MT, Krogsgaard K, Gluud C.
Cochrane Database Syst Rev. 2004;2004(2):CD002904. doi: 10.1002/14651858.CD002904.pub2.
Management of viral hepatitis C.
Leung NW.
J Gastroenterol Hepatol. 2002 Feb;17 Suppl:S146-54. doi: 10.1046/j.1440-1746.17.s1.13.x.
